Follow The Filings

BHVN Biohaven

Biohaven earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by BHVN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BHVN insider trades
  • $33.1M bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. John W Childs Director
    Buy
    $864K 28,400 shares at $30.43 +1.2% to stake
    Traded Mar 4, 2025 Filed Mar 9
    ↗
  2. George C. Clark VP, Chief Accounting Officer
    Buy
    $145K 17,000 shares at $8.52 +567% to stake
    Traded Nov 17, 2025 Filed Nov 18, 2025
    ↗
  3. Gregory Bailey Director
    Buy
    $3M 400,000 shares at $7.50 +25% to stake
    Traded Nov 13, 2025 Filed Nov 17, 2025
    ↗
  4. Vlad Coric CEO
    Buy
    $5M 666,666 shares at $7.50 +902% to stake
    Traded Nov 13, 2025 Filed Nov 17, 2025
    ↗
  5. John W Childs Director
    Buy
    $25M 3,333,333 shares at $7.50 +144% to stake
    Traded Nov 13, 2025 Filed Nov 17, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 5 share withholdings for taxes, 5 option exercises, and 2 gifts.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
424B5 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.